Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Lipin 1 (LPIN1) Peptide

LPIN1 Reactivité: Humain Hôte: Synthetic BP, IHC, WB
N° du produit ABIN979544
  • Antigène Tous les produits Lipin 1 (LPIN1)
    Lipin 1 (LPIN1)
    Origine
    Humain
    Source
    • 4
    Synthetic
    Application
    Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
    Attributs du produit
    This is a synthetic peptide designed for use in combination with anti-LPIN1 antibody (Catalog #: ARP53826_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
    Purification
    Purified
  • Indications d'application
    Each Investigator should determine their own optimal working dilution for specific applications.
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
    Concentration
    1 mg/mL
    Buffer
    Final peptide concentration is 1 mg/mL in PBS.
    Conseil sur la manipulation
    Avoid repeated freeze-thaw cycles.
    Stock
    -20 °C
    Stockage commentaire
    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Antigène
    Lipin 1 (LPIN1)
    Synonymes
    LPIN1 Peptide, pap1 Peptide, PAP1 Peptide, 4631420P06 Peptide, Kiaa0188 Peptide, Lipin1 Peptide, fld Peptide, mKIAA0188 Peptide, zgc:194552 Peptide, zgc:194558 Peptide, lipin1 Peptide, lipin 1 Peptide, phosphatidate phosphatase LPIN1 Peptide, LPIN1 Peptide, lpin1 Peptide, LOC100539289 Peptide, Lpin1 Peptide
    Sujet
    This gene represents a candidate gene for human lipodystrophy, characterized by loss of body fat, fatty liver, hypertriglyceridemia, and insulin resistance. Mouse studies suggest that LPIN1 functions during normal adipose tissue development and may also play a role in human triglyceride metabolism. This gene represents a candidate gene for human lipodystrophy, characterized by loss of body fat, fatty liver, hypertriglyceridemia, and insulin resistance. Mouse studies suggest that this gene functions during normal adipose tissue development and may also play a role in human triglyceride metabolism. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.

    Alias Symbols: DKFZp781P1796, KIAA0188, PAP1

    Protein Size: 890
    Poids moléculaire
    98 kDa
    ID gène
    23175
    NCBI Accession
    NM_145693, NP_663731
    UniProt
    Q14693
Vous êtes ici:
Support technique